JP6423349B2 - Ｎ−置換３，４−ビス（カテコール）ピロール化合物、その調製、及びガンの治療のためのその使用 - Google Patents

Ｎ−置換３，４−ビス（カテコール）ピロール化合物、その調製、及びガンの治療のためのその使用 Download PDF

Info

Publication number
JP6423349B2
JP6423349B2 JP2015537212A JP2015537212A JP6423349B2 JP 6423349 B2 JP6423349 B2 JP 6423349B2 JP 2015537212 A JP2015537212 A JP 2015537212A JP 2015537212 A JP2015537212 A JP 2015537212A JP 6423349 B2 JP6423349 B2 JP 6423349B2
Authority
JP
Japan
Prior art keywords
cancer
compound
cells
compound according
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015537212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015534958A (ja
JP2015534958A5 (https=
Inventor
パスカル・コラン
マクシム・エゴロフ
ベルナール・デルペシュ
ジョアンナ・バカラ
マリア・アチャブ
ジェローム・ビニョン
オディル・トワゾン
ミシェル・ベネシ
Original Assignee
センター ナショナル ド ラ ルシェルシュ サイエンティフィーク
センター ナショナル ド ラ ルシェルシュ サイエンティフィーク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by センター ナショナル ド ラ ルシェルシュ サイエンティフィーク, センター ナショナル ド ラ ルシェルシュ サイエンティフィーク filed Critical センター ナショナル ド ラ ルシェルシュ サイエンティフィーク
Publication of JP2015534958A publication Critical patent/JP2015534958A/ja
Publication of JP2015534958A5 publication Critical patent/JP2015534958A5/ja
Application granted granted Critical
Publication of JP6423349B2 publication Critical patent/JP6423349B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2015537212A 2012-10-16 2013-10-14 Ｎ−置換３，４−ビス（カテコール）ピロール化合物、その調製、及びガンの治療のためのその使用 Expired - Fee Related JP6423349B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1259868 2012-10-16
FR1259868A FR2996847B1 (fr) 2012-10-16 2012-10-16 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer
PCT/EP2013/071445 WO2014060366A1 (fr) 2012-10-16 2013-10-14 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer

Publications (3)

Publication Number Publication Date
JP2015534958A JP2015534958A (ja) 2015-12-07
JP2015534958A5 JP2015534958A5 (https=) 2018-02-22
JP6423349B2 true JP6423349B2 (ja) 2018-11-14

Family

ID=47425104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015537212A Expired - Fee Related JP6423349B2 (ja) 2012-10-16 2013-10-14 Ｎ−置換３，４−ビス（カテコール）ピロール化合物、その調製、及びガンの治療のためのその使用

Country Status (8)

Country Link
US (1) US9546159B2 (https=)
EP (1) EP2909171B1 (https=)
JP (1) JP6423349B2 (https=)
AU (1) AU2013331764B2 (https=)
CA (1) CA2888379A1 (https=)
ES (1) ES2608781T3 (https=)
FR (1) FR2996847B1 (https=)
WO (1) WO2014060366A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3022244B1 (fr) * 2014-06-17 2016-07-01 Centre Nat De La Rech Scient (Cnrs) Utilisation d'un nouveau compose 3-aryl-4-catechol-pyrrole-n-propanol et ses derives pour le traitement du cancer et des pathologies associees a une angiogenese excessive
CN121154883A (zh) * 2020-05-25 2025-12-19 医工瑞思(福建)工程研究中心有限公司 一种大面积创伤急救敷料套件及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019045A1 (en) * 1992-03-26 1993-09-30 E.I. Du Pont De Nemours And Company Arthropodicidal amides
DE19756261A1 (de) * 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
GB9821975D0 (en) * 1998-10-08 1998-12-02 Pharma Mar Sa New cytotoxic alkaloids
WO2008064317A1 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Lipophilic opioid receptor active compounds
WO2008064318A2 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Peripheral opioid receptor active compounds

Also Published As

Publication number Publication date
CA2888379A1 (fr) 2014-04-24
JP2015534958A (ja) 2015-12-07
ES2608781T3 (es) 2017-04-17
FR2996847B1 (fr) 2014-12-05
AU2013331764B2 (en) 2017-11-16
EP2909171A1 (fr) 2015-08-26
WO2014060366A1 (fr) 2014-04-24
FR2996847A1 (fr) 2014-04-18
AU2013331764A1 (en) 2015-05-21
US9546159B2 (en) 2017-01-17
EP2909171B1 (fr) 2016-09-28
US20150344460A1 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
JP6193268B2 (ja) Ｃｄｋ８／ｃｄｋ１９選択的阻害剤、ならびに癌のための抗転移および化学防御の方法におけるそれらの使用
El Rayes et al. Convenient Synthesis and Anticancer Activity of Methyl 2-[3-(3-Phenyl-quinoxalin-2-ylsulfanyl) propanamido] alkanoates and N-Alkyl 3-((3-Phenyl-quinoxalin-2-yl) sulfanyl) propanamides
AU2014256546B2 (en) Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level
EP2994460B1 (en) Compounds for treatment of angiogenesis-mediated diseases
CN107849050B (zh) 化合物
AU2017258304B2 (en) 1,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases
Darvin et al. Sorghum polyphenol suppresses the growth as well as metastasis of colon cancer xenografts through co-targeting jak2/STAT3 and PI3K/Akt/mTOR pathways
WO2018204370A1 (en) Cx3cr1 small molecule antagonists, and methods using same
WO2018068665A1 (zh) 微管蛋白抑制剂
JP6423349B2 (ja) Ｎ−置換３，４−ビス（カテコール）ピロール化合物、その調製、及びガンの治療のためのその使用
Yuan et al. Pioneering 4, 11-Dioxo-4, 11-dihydro-1 H-anthra [2, 3-d] imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy
US9399644B2 (en) [1,3] dioxolo [4,5-G] quinoline-6(5H)thione derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancer
Liu et al. EtNBSe-PDT inhibited proliferation and induced autophagy of HNE-1 cells via downregulating the Wnt/β-catenin signaling pathway
CN102725298A (zh) 作为组蛋白脱乙酰酶抑制剂的羟基取代的金(iii)卟啉络合物
Wang et al. Design, synthesis and evaluation of novel Cyclopropanesulfonamide derivatives for the treatment of EGFRC797S mutation in Non-Small cell lung cancer
JP7672153B2 (ja) クロメン系化合物、それらの方法及び使用
Li et al. The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation
Wang et al. The discovery of novel sanjuanolide derivatives as chemotherapeutic agents targeting castration-resistant prostate cancer
Yao et al. Design, synthesis and biological assessment of erlotinib-1, 2, 3-triazole derivatives for anticancer applications
JP2025525185A (ja) シクロペンテノンをベースとする抗がん剤
KR20210147876A (ko) 페닐렌 디벤즈아미드계 화합물 및 이를 유효성분으로 포함하는 암질환 예방 또는 치료용 약제학적 조성물
US9994515B2 (en) Aryl naphthyl methanone oxime(s) and process for preparation thereof
Generation et al. Molecular Sciences
Manik et al. Design, Synthesis, and in Vitro and in Vivo Biological Evaluation of 2-Amino-Naphtho [2, 3-B] Thiophene 4, 9-Dione Derivatives as Potent Anti-Cancer Agents

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161003

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170710

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170713

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171010

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20180110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180615

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20180625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180713

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180820

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181018

R150 Certificate of patent or registration of utility model

Ref document number: 6423349

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees